← Leaderboards
Catherine M Verfaillie
University Of Minnesota Twin Cities
$8,968,595
Attributed
$8,968,595
Total exposure
18
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2005–06$2M$1.5M$1M$500K$0
'05
'06
Funding mix
By agency
NIH$13,831,593 · 19
By mechanism
R01$7,633,083 · 8
U19$4,862,998 · 2
S10$471,520 · 1
P01$453,126 · 2
T15$370,524 · 1
R13$22,000 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota Twin Cities
Same institution · by research overlap
- Philip McGlave$1,430,518
- Jeffrey McCullough$5,022,716
- Chester B Whitley$15,153,874
- Perry B Hackett$3,902,841
- Bianca M Conti-Fine$5,252,354
Others in their field
Top investigators on “Cell Differentiation”
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- John M Lachin · George Washington University$118,672,444
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- David Heimbrook · Leidos Biomedical Research, Inc.$116,528,280
- Israel David Goldman · Yeshiva University$52,846,708
Research focus
Cell DifferentiationStem Cell TransplantationLaboratory MouseGene ExpressionHematopoietic Stem CellsTissue /Cell CultureGenetically Modified AnimalsDisease /Disorder ModelBone MarrowMesenchymeTransfection /Expression VectorHuman SubjectCell Population StudyPluripotent Stem CellsScid MouseGenetic TransductionNod MouseCell ProliferationGenetic ManipulationGene TherapyHuman TissueImmunocytochemistryImmunologic Substance Development /PreparationDiabetes Mellitus Therapy
Grant awards (49)
Mesenchymal Stem Cell Therapy a1 antitrypsin deficiency$343,042
R01 · FY2006 · HL · contact PI
Multipotent Stem Cells in Post Natal Bone Marrow$297,272
R01 · FY2006 · DK · contact PI
Genetic Control of Hematopoietic Development$229,859
P01 · FY2006 · CA · contact PI
MInnesota Human MAPC Training Grant$127,065
T15 · FY2006 · HL · contact PI
Scientific Meeting$5,000
R13 · FY2006 · DK · contact PI
Stem Cells$5,000
R13 · FY2006 · GM · contact PI
BONE MARROW ASPIRATE FOR HEMATOPOIETIC AND MESENCHYMAL STEM CELLS$4,304
M01 · FY2006 · RR · contact PI
Mesenchymal Stem Cell Therapy a1 antitrypsin deficiency$351,878
R01 · FY2005 · HL
Multipotent Stem Cells in Post Natal Bone Marrow$304,425
R01 · FY2005 · DK
Genetic Control of Hematopoietic Development$223,267
P01 · FY2005 · CA
MInnesota Human MAPC Training Grant$123,509
T15 · FY2005 · HL
Stem Cells$12,000
R13 · FY2005 · GM
BONE MARROW ASPIRATE FOR HEMATOPOIETIC AND MESENCHYMAL STEM CELLS$5,906
M01 · FY2005 · RR
Phenotypic and Functional Characterization of Beta Cell*$1,204,861
U19 · FY2004 · DK
Mesenchymal Stem Cell Therapy a1 antitrypsin deficiency$353,581
R01 · FY2004 · HL
Multipotent Stem Cells in Post Natal Bone Marrow$304,425
R01 · FY2004 · DK
Stem Cell Therapy for Hemophilia A$297,000
R01 · FY2004 · HL
NEUROECTODERM DIFFERENTIATION FROM MESENCHYMAL STEM CELL$297,000
R01 · FY2004 · DK
MInnesota Human MAPC Training Grant$119,950
T15 · FY2004 · HL
Bone Marrow Aspirate for Hematopoietic and Mesenchymal Stem Cells$8,132
M01 · FY2004 · RR
Phenotypic and Functional Characterization of Beta Cell*$1,223,775
U19 · FY2003 · DK
FACS Vantage SE$471,520
S10 · FY2003 · RR
Stem Cell Therapy for Hemophilia A$369,553
R01 · FY2003 · HL
Mesenchymal Stem Cell Therapy: a1 antitrypsin deficiency$363,975
R01 · FY2003 · HL
Multipotent Stem Cells in Post Natal Bone Marrow$304,425
R01 · FY2003 · DK
NEUROECTODERM DIFFERENTIATION FROM MESENCHYMAL STEM CELL$295,819
R01 · FY2003 · DK
MIGRATION AND ADHESION OF CHRONIC MYELOGNEOUS LEUKEMIA C$285,255
R01 · FY2003 · HL
Phenotypic and Functional Characterization of Beta Cell*$165,000
U19 · FY2003 · DK
NEUROECTODERM DIFFERENTIATION FROM MESENCHYMAL STEM CELL$59,220
R01 · FY2003 · DK
Phenotypic and Functional Characterization of Beta Cell*$1,143,570
U19 · FY2002 · DK
NEUROECTODERM DIFFERENTIATION FROM MESENCHYMAL STEM CELL$297,600
R01 · FY2002 · DK
Stem Cell Therapy for Hemophilia A$297,000
R01 · FY2002 · HL
Multipotent Stem Cells in Post Natal Bone Marrow$290,506
R01 · FY2002 · DK
MIGRATION AND ADHESION OF CHRONIC MYELOGNEOUS LEUKEMIA C$277,977
R01 · FY2002 · HL
Stem Cell Therapy for Hemophilia A$69,400
R01 · FY2002 · HL
SYMMETRICAL CELL DIVISIONS AND STEM CELL EXPANSION$0
P01 · FY2002 · CA
Islet Cells Derived from Multipotent Adult Stem Cells$0
U19 · FY2002 · DK
Characterization of Beta Cell Stem Cells$1,125,792
U19 · FY2001 · DK
GENE THERAPY FOR PH+ ALL$296,881
R01 · FY2001 · CA
NEUROECTODERM DIFFERENTIATION FROM MESENCHYMAL STEM CELL$294,477
R01 · FY2001 · DK
Stem Cell Therapy for Hemophilia A$281,965
R01 · FY2001 · HL
MIGRATION AND ADHESION OF CHRONIC MYELOGNEOUS LEUKEMIA C$270,911
R01 · FY2001 · HL
Islet Cells Derived from Multipotent Adult Stem Cells$0
U19 · FY2001 · DK
SYMMETRICAL CELL DIVISIONS AND STEM CELL EXPANSION$0
P01 · FY2001 · CA
GENE THERAPY FOR PH+ ALL$288,826
R01 · FY2000 · CA
MIGRATION AND ADHESION OF CHRONIC MYELOGNEOUS LEUKEMIA C$264,050
R01 · FY2000 · HL
BETA-1 INTEGRINS &HEMATOPOIETIC PROGENITORS ENGRAFTMENT$250,001
R01 · FY2000 · DK
ANTISENSE DRUG RESISTANT GENE THERAPY FOR CML$226,619
R01 · FY2000 · CA
SYMMETRICAL CELL DIVISIONS AND STEM CELL EXPANSION$0
P01 · FY2000 · CA